Aurobindo Pharma - News
NSE: AUROPHARMA | BSE: 524804
₹1,697.70
As on 29-Sep-2026IST
Market cap
₹97,987 Cr
Revenue (TTM)
₹34,935 Cr
P/E Ratio
26.4
P/B Ratio
2.5
Div. Yield
0.2 %
Quarterly Updates
Annual Reports
NSE: AUROPHARMA | BSE: 524804
₹1,697.70
As on 29-Sep-2026IST
Market cap
₹97,987 Cr
Revenue (TTM)
₹34,935 Cr
P/E Ratio
26.4
P/B Ratio
2.5
Div. Yield
0.2 %
Annual Reports